Socrates V. Herrera
Cali, VAC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax.
Journal: PLoS neglected tropical diseases
Published: October 18, 2025
Correction: Rojas-Peña et al. Individualized Transcriptional Resolution of Complicated Malaria in a Colombian Study. J. Pers. Med. 2018, 8, 29.
Journal: Journal of personalized medicine
Published: September 17, 2024
A Short-Read Amplicon Sequencing Protocol and Bioinformatic Pipeline for Ecological Surveillance of Dipteran Disease Vectors.
Journal: Molecular ecology resources
Published: July 29, 2024
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa.
Journal: PloS one
Published: May 07, 2024
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with sera from Plasmodium falciparum endemic areas of Africa.
Journal: bioRxiv : the preprint server for biology
Published: April 25, 2024
Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites.
Journal: Scientific reports
Published: October 28, 2023
Genomics of Plasmodium vivax in Colombia reveals evidence of local bottle-necking and inter-country connectivity in the Americas.
Journal: Scientific reports
Published: July 03, 2023
Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.
Journal: The Lancet. Infectious diseases
Published: June 02, 2023
Seroprevalence of viral and bacterial pathogens among malaria patients in an endemic area of southern Venezuela.
Journal: Infectious diseases of poverty
Published: November 04, 2022
A SARS-CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients.
Journal: Frontiers in immunology
Published: February 20, 2022
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
Journal: Frontiers in immunology
Published: January 16, 2022
Last Updated: 09/26/2026